| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Tilorone |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Non-steroidal anti-inflammatory agent (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Cromoglicic acid |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| intoxication par un médicament anti-inflammatoire local |
Causative agent (attribute) |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Valdecoxib (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Budesonide (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Halcinonide (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Alclometasone (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Clobetasone (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Mometasone (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Deflazacort (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Fluticasone propionate (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Fluticasone (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Liver derivative complex |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Desiccated liver preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Injectable liver preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing liver extract (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Hepacon liver extract D 0.1mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Topical anti-inflammatory prep[1] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Topical anti-inflammatory prep[2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Other preps for inflamed joints |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| agent anti-inflammatoire |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Liver derivative complex 25.5mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Ciclesonide (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing etanercept (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Adalimunab 40mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Etanercept 25mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Adalimumab 40mg injection solution 0.8mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing adalimumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing tumor necrosis factor alpha inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate 20mg inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate 20mg/2mL nebulization unit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate 5mg inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate 5mg inhaler+spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate 5mg breath-actuated aerosol inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler+spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Cromolyn sodium 100mg/5ml oral concentrate solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate+isoprenaline sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing cromoglicate sodium and salbutamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate 2% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing sodium cromoglycate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Inhaled sodium cromoglycate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing sodium cromoglycate in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing cromoglicic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing cromolyn sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate [gastro-intestinal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate [asthma] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate compounds |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Cromolyn sodium 20mg/2 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Cromolyn sodium 0.8mg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Cromolyn sodium 20mg/amp solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Cromolyn sodium 100mg/5mL gas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Cromolyn sodium 5.2mg/spr solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Cromolyn sodium 10mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Cromolyn sodium 800mcg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Cromolyn sodium 40mg/spr solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Cromolyn sodium 8.1g spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Cromolyn sodium 40mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Cromolyn sodium 0.8mg/spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Ophthalmic cromolyn sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Etanercept 50mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Sodium cromoglycate+xylometazoline hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Tumor necrosis factor alpha inhibitor |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Liver extract (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Local anti-infective and anti-inflammatory poisoning |
Causative agent (attribute) |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
| Otic anti-inflammatory preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]